Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Accumulated Expenses: 2023

Historic Other Accumulated Expenses for Eton Pharmaceuticals (ETON) over the last 1 years, with Dec 2023 value amounting to $5.4 million.

  • Eton Pharmaceuticals' Other Accumulated Expenses was N/A to $675,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $675,000, marking a year-over-year change of. This contributed to the annual value of $5.4 million for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Eton Pharmaceuticals' Other Accumulated Expenses is $5.4 million.
  • In the past 5 years, Eton Pharmaceuticals' Other Accumulated Expenses registered a high of $5.4 million during FY2023, and its lowest value of $5.4 million during FY2023.
  • For the 1-year period, Eton Pharmaceuticals' Other Accumulated Expenses averaged around $5.4 million, with its median value being $5.4 million (2023).